
India Pesticides Ltd Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- →India Pesticides Limited aims to achieve INR 3,000 crores revenue by March 2031.
- →The Shalvis subsidiary is expected to contribute around INR 1,000 crores by FY31.
- →Existing plants at Dewa Road, Sandila, and formulation facilities are projected to generate the remaining INR 2,000 crores.
- →For the current year, a revenue growth of 15% to 20% is expected.
- →Volume growth of about 30% was reported in Q4 FY26; continued growth anticipated with full utilization of new capacities.
- →New product introductions and backward integration to support stable EBITDA margins around 18%.
- →Strategic expansions underway, including capacity additions at Hamirpur and Shalvis facilities, expected to bolster volumes and revenues.
- →Market conditions, supply chain stability, and price adjustments are factored into growth outlook.
Margin guidance
Category 3- →India Pesticides expects revenue growth of 15-20% for the current financial year, maintaining earlier guidance.
- →EBITDA margin is anticipated to remain steady at around 18%.
- →By FY31, the company targets INR 3,000 crores in revenue, with INR 1,000 crores expected from the Shalvis subsidiary and INR 2,000 crores from existing plants.
- →Capacity additions and backward integration efforts aim to sustain margins despite raw material cost pressures.
- →Continuous product pipeline expansion via R&D and increased utilization levels support long-term earnings growth.
- →Strategic investments, including INR 135 crores capex over FY27 (INR 45 crores standalone and INR 90 crores subsidiary), are expected to bolster future profitability.
- →Conserved funds and low leverage are intended to improve intrinsic investor value and enable funded expansions without excessive debt.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →India Pesticides Limited has taken a term loan of around INR 27 crores at an 8% interest rate for its new 100% subsidiary.
- →The company’s blended cost of funds for working capital is approximately 7.2% to 7.3%, with some short-term funds borrowed against FDR at 50 basis points over FDR.
- →The current credit rating is A+, with the next review due in September.
- →Capex plans for FY27 are INR 45 crores for the standalone entity and INR 90 crores for the subsidiary, mostly funded through internal accruals.
- →A small loan may be taken by the 100% subsidiary to support the capex.
- →There is no indication of any immediate equity fundraising; the company prefers internal accruals and minimal debt to fund expansions.
Order book
Capex plans
Yes- →India Pesticides has a capex budget of INR 45 crores for FY27 for the standalone entity and INR 90 crores for its 100% subsidiary, primarily funded through internal accruals.
- →Expansion plans include the Hamirpur facility development, with new technical blocks progressing as planned.
- →Capacity augmentation at Sandila site is mostly completed; only intermediate and technical grade product additions planned with some efficiency improvements.
- →Shalvis subsidiary is investing INR 90 crores in capex, including new plant operationalization expected to contribute to revenue by FY27-FY28.
- →Backward integration initiatives underway to improve supply chain stability and reduce import dependency.
- →The company focuses on strategic investments in product portfolio enhancement, manufacturing capabilities, and backward integration.
- →Capital work-in-progress of around INR 68 crores mainly attributed to Shalvis subsidiary with capitalization expected partly in Q4 FY26 and remainder by FY27-FY28.
How does India Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?
Pro featureSee full Fertilizers & Agrochemicals sector rankings
Want more stocks like India Pesticides Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio